1-2 of 2
Yifan Tu, MD PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Ibrutinib and Venetoclax Target Distinct Subpopulation of CLL Cells: Rationale for Drug Combination and Implication of Minimal Residual Disease Eradication

Y. Lynn Lynn Wang, MD PhD, Carrie Franzen, PhD, Shengchun Wang, MD PhD, Girish Venkataraman, MD MBBS, Lei Li, MS, Nifang Niu, PhD, Madina Sukhanova, PhD, Yifan Tu, MD PhD, Juehua Gao, MD PhD, Yi-Hua Chen, MD, Shuo Ma, MD PhD, Richard A. Larson, MD, Lu Pin, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 475.
https://doi.org/10.1182/blood-2019-125396
Published: 2019
Journal Articles

ETO2 Regulates Cell-Fate Genes and Controls Relapse in Acute Myeloid Leukemia

Nickolas Steinauer, BA, Chun Guo, MS, Chunfa Huang, PhD, Yifan Tu, MD PhD, Carl E. Freter, MD PhD, Jinsong Zhang, PhD MS
Journal: Blood
Blood (2017) 130 (Supplement 1): 3808.
https://doi.org/10.1182/blood.V130.Suppl_1.3808.3808
Published: 2017